The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Purpose This cardiac dysfunction in patients with Duchenne muscular dystrophy is associated
with minor cardiac damage as indicated by elevation of plasma cardiac troponin I (cTnI). The
purpose of this study is to investigate whether the administration of Carvedilol can suppress
the minor cardiac damage and prevent deterioration of cardiac function.